Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Navigating Transition: Treatment to "Survivor Thriver"

      August 12, 2011
      By Sharon Francz, LPN, BHA
      Publication
      Article
      Oncology Nursing NewsAugust 2011
      Volume 5
      Issue 4

      The Breast or Oncology Nurse Navigator (ONN) can be instrumental to ensuring that a patient transitions from active treatment to becoming a 'survivor thriver.'

      Breast cancer and its treatment present many personal and physical challenges. Much like the variations in their individual diagnoses, each individual patient will likely have vastly different recovery goals after treatment, with varying physical, psychological, social, and spiritual objectives. Additionally, for each person, the transition from active treatment to survivorship occurs; however, the pace is often much slower than individuals are prepared to handle.

      Whether it is oral or intravenous chemotherapy, radiation, or surgical intervention, treatment involves actively fighting the cancer. This offers a level of comfort, as patients are constantly checking in with physicians and nurses. The interactions provide reassurance that either the treatment is progressing or the cancer is gone.

      When the treatment phase ends, the emotional ramifications of what one has been through may cause a flood of emotions in the newly “cancer-free” individual. Questions arise such as, “Will the cancer return?” and “How will I know if the cancer returns?” Patients eagerly anticipate the completion of treatment; however, the end of treatment does not always bring them comfort. Transitioning from active treatment to one’s “old” life leaves many patients feeling lost and in a constant state of waiting for “what’s next.”

      The Breast or Oncology Nurse Navigator (ONN) can be instrumental to ensuring that a patient transitions from active treatment to becoming a “survivor thriver.” From the time of engagement, the navigator is “hand in hand” with the patient, identifying obstacles and barriers that may derail a successful completion of treatment and transition to survivorship. This is the navigator’s role and area of expertise.

      As with any relationship, communication is essential to a successful navigator-patient relationship. Navigators can be instrumental in educating patients and helping them develop a survivorship care plan. These individualized survivorship blueprints should start as soon as a patient is diagnosed with cancer.

      Survivorship care plans should include:

      • Complete history of cancer treatment from time of diagnosis to end of active care. This background should include type of surgery, chemotherapy and radiation regimens, as well as names of healthcare providers and treatment facilities.
      • Prevention and screening schedule for recurrent and new cancers
      • Education guidelines for the patient on how to recognize latent physical and psychosocial effects of cancer treatment
      • Surveillance schedule frequency (follow-up visit schedule), including coordination between the patient’s primary care providers and specialists
      • Intervention care plan for cancer recurrence
      • Resources and support services available to the patient and family/caregiver in her community

      Survivorship care plans consider the patient’s life before cancer, the treatment prescribed and completed, and how to integrate this plan into the patient’s “new” life. Being a survivor is a continuum of cancer care.

      Resources for Survivors:

      CancerCare©

      1-800-813-HOPE (4673)

      www.cancercare.org

      Cancer Support Community

      1-888-793-9355

      www.cancersupportcommunity.org

      Facing Forward: Life After Cancer Treatment

      www.cancer.gov

      Living Beyond Breast Cancer

      1-888-753-LBBC (5222)

      www.lbbc.org

      National Coalition for Cancer Survivorship

      1-888-650-9127

      www.canceradvocacy.org

      Recently, patient navigation has become a focus in healthcare. The reason for the surge in patient navigation is the increased fragmentation of how healthcare is delivered. The complexity of navigating healthcare facilities, increase in available treatment options, decrease in participating specialty providers, and struggling economy have further complicated the process of completing treatment and entering survivorship.

      The good news is breast cancer care has had a patient navigation standard since 2009, when the National Accreditation Programs for Breast Centers (NAPBC) instituted this mandate. The American College of Surgeons Commission on Cancer will soon be adding a new standard on patient navigation so that all patients, regardless of their cancer diagnosis, will have the benefit of a navigator throughout cancer treatment. The Institute of Medicine’s Cancer Care for the Whole Patient report stressed that all cancer care should provide and ensure appropriate psychosocial health services, facilitate effective communication, identify each patient’s psychosocial needs, design and implement a plan that links the patient with needed psychosocial care, coordinate biomedical and psychosocial care, engage and support patients in managing illness, and systematically follow up on evaluating and adjusting this plan.

      Individuals may benefit from a navigator at any stage of cancer treatment. Patients with breast cancer who have not been connected to a navigator may locate one by contacting their oncologist or cancer center and asking if they have a Breast Cancer Navigator, Patient Navigator, or ONN on staff. Patients can also locate an ONN by visiting the Patient page at www.nconn.org and seeing if there is a navigator located near them.

      Sharon Francz, LPN, BHA, is an oncology nurse navigator and the president and co-founder of the National Coalition of Oncology Nurse Navigators (NCONN).

      Reference:

      Institute of Medicine. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: National Academies Press; 2007.

      Articles in this issue

      gynecologic cancer
      Cervical Cancer Screening Guidelines Updated: Changes Mean Less Intrusive Prevention Strategies, Lower Morbidity
      Paclitaxel Shortage May Add Millions to Cost of Ovarian Cancer Care
      ASCO 2011: What Nurses Need to Know
      Metformin May Decrease Diabetics' Breast Cancer Risk
      Yoga Benefits Patients With Breast Cancer
      Breast Cancer Survivors Vulnerable to Long-Term Work Loss
      Survivorship Care Plans Do Not Improve Outcomes for Patients With Breast Cancer
      Navigating Transition: Treatment to "Survivor Thriver"
      Truth in Advertising

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Image of a woman with gray hair on a light blue background
      Photo of a man wearing scrubs in front of a blue background
      Related Content

      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      Rx Road Map: Daratumumab and Hyaluronidase-fihj

      Sylwia Zielinska, RN
      May 7th 2025
      Article

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.


      lung cancer

      Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)

      Denise Rouse, MMS, PA-C;Margaret Colleton, MMS, MSW, PA-C
      December 19th 2024
      Article

      APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.


      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.

      Understanding the Role of an Oncology Research Nurse

      Darlene Dobkowski, MA
      September 26th 2024
      Article

      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.


      nurse talking to male patient in radiation machine

      How Nurses Help Patients With Prostate Cancer During Radiation Treatment

      Alex Biese
      September 23rd 2024
      Article

      Nurses play a crucial role for patients with prostate cancer undergoing radiation treatment, according to a radiation oncology nurse.


      lungs

      Lung Cancer Trial Falls Short of Goal, But Presents Clinical Benefit in Some Patients

      Dylann Cohn-Emery
      September 17th 2024
      Article

      While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed promising long-term benefits in patients with advanced NSCLC.


      Suriyo - stock.adobe.com

      Innovative Program Reduces Nurse Turnover and Fosters Development

      Heather Wood, RN, OCN;Marie Garcia, RN, OCN
      Published: September 12th 2024 | Updated: September 12th 2024
      Article

      The US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.

      Related Content

      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      Rx Road Map: Daratumumab and Hyaluronidase-fihj

      Sylwia Zielinska, RN
      May 7th 2025
      Article

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.


      lung cancer

      Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)

      Denise Rouse, MMS, PA-C;Margaret Colleton, MMS, MSW, PA-C
      December 19th 2024
      Article

      APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.


      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.

      Understanding the Role of an Oncology Research Nurse

      Darlene Dobkowski, MA
      September 26th 2024
      Article

      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.


      nurse talking to male patient in radiation machine

      How Nurses Help Patients With Prostate Cancer During Radiation Treatment

      Alex Biese
      September 23rd 2024
      Article

      Nurses play a crucial role for patients with prostate cancer undergoing radiation treatment, according to a radiation oncology nurse.


      lungs

      Lung Cancer Trial Falls Short of Goal, But Presents Clinical Benefit in Some Patients

      Dylann Cohn-Emery
      September 17th 2024
      Article

      While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed promising long-term benefits in patients with advanced NSCLC.


      Suriyo - stock.adobe.com

      Innovative Program Reduces Nurse Turnover and Fosters Development

      Heather Wood, RN, OCN;Marie Garcia, RN, OCN
      Published: September 12th 2024 | Updated: September 12th 2024
      Article

      The US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.

      Latest Conference Coverage

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Acupuncture Use in BC Predicted by Social Determinants of Health

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Blinatumomab-Linked ICANS Cases Higher Than Previously Reported

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.